TY  - JOUR
AU  - Villanueva, V
AU  - Ojeda, J
AU  - Rocamora, R A
AU  - Serrano-Castro, P J
AU  - Parra, J
AU  - Rodríguez-Uranga, J J
AU  - Bathal, H
AU  - Viteri, C
PY  - 2016
DO  - 10.1016/j.nrl.2016.04.014
UR  - http://hdl.handle.net/10668/10222
T2  - Neurologia (Barcelona, Spain)
AB  - The objective of the EPICON Project is to develop a set of recommendations on how to adequately switch from carbamazepine (CBZ) and oxcarbazepine (OXC) to eslicarbazepine acetate (ESL) in some patients with epilepsy. A steering committee drafted a...
LA  - en
KW  - Acetato de eslicarbazepina
KW  - Cambio
KW  - Carbamazepina
KW  - Carbamazepine
KW  - Drug switching
KW  - Eslicarbazepine acetate
KW  - Methodology
KW  - Metodología
KW  - Oxcarbazepina
KW  - Oxcarbazepine
KW  - Situaciones
KW  - Situations
KW  - Anticonvulsants
KW  - Carbamazepine
KW  - Consensus
KW  - Delphi Technique
KW  - Dibenzazepines
KW  - Drug Substitution
KW  - Epilepsy
KW  - Guidelines as Topic
KW  - Humans
KW  - Neurologists
KW  - Oxcarbazepine
KW  - Surveys and Questionnaires
KW  - Voltage-Gated Sodium Channel Blockers
TI  - EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy.
T2  - Consenso Delphi EPICON: recomendaciones sobre el manejo adecuado del cambio a acetato de eslicarbazepina en epilepsia.
TY  - research article
VL  - 33
ER  -